Polypeptide factors from colostrum

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530350, 530832, A61K 3702

Patent

active

053710738

ABSTRACT:
IgE binding factors (IgE-bfs) with IgE suppressor (IgE-SF) activity obtainable from human colostrum in an enriched form, a method for the prevention and/or the treatment of allergy by administering the IgE-bfs and pharmaceutical compositions comprising said IgE-bfs.

REFERENCES:
patent: 3553317 (1971-01-01), Michaelson et al.
patent: 4582580 (1986-04-01), Goudal et al.
patent: 4644056 (1987-02-01), Kothe et al.
patent: 4816563 (1989-03-01), Wilson et al.
Richie et al., Journal of Immunology, 129:3 (Sep. 1982) pp. 1116-1119.
Crago et al., Surv. Immunol. Res. 2 (1983) pp. 164-169.
Jarrett, et al. Selective Suppression of IgE Antibody Responsiveness by Maternal Influence, Nature, 280: 145-147 (1979).
Roberts et al., "Specific Suppression of Rat IgE Responses with Milk from Immunized Females and with Feeds of Serum Antibody", Immunology, 48:195-199 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptide factors from colostrum does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide factors from colostrum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide factors from colostrum will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-214528

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.